Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-04

Clinical Trial Update: Evaluation of the Free α-hemoglobin Pool in the Red Blood Cells : Prognostic Marker and Severity Index in Thalassemic Syndromes [NA]

View source ↗

Summary

This clinical trial update reports on evaluating the free α-hemoglobin pool in red blood cells as a prognostic marker and severity index in thalassemia syndrome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Thalassemic Syndromes | NA | Status: COMPLETED